Patients can digitally record benefits and side effects
Munich-based startup XO Life has developed a platform that allows patients to digitally record their treatment progress.
28.2.2021
The Munich-based start-up XO Life (formerly Medikura) has developed an innovative digital platform that revolutionizes the monitoring of drug effectiveness and safety. The “ImpactMonitor” enables patients to digitally document treatment processes and relevant side effects. This data, including quality of life information, is systematically collected, pseudonymized and prepared for pharmaceutical companies and research institutes. They can use the data to improve pharmacovigilance and meet legal requirements.
Would you like to find out more or are you interested in XO Life?
Get in touch now, get a demo or answer individual questions in a personal conversation.
XO Life News
Discover even more news
brite™ Launches Nationwide Cooperation with Germany's Federal Association of Pulmonologists to Support Asthma and COPD Patients Digitally
After a successful pilot, brite™ is now available free to asthma and COPD patients across Germany through their pulmonologist.
XO Life Secures €4 Million in New Funding to Accelerate European Expansion and Scale its AI-Driven Patient-Pharma Platform
XO Life closes €4M funding round led by Fil Rouge Capital to accelerate European expansion and scale the brite platform internationally.
%20(1).jpg)
Combining quality and innovation: AAA-Pharma starts cooperation with XO Life
AAA-Pharma and XO Life combine high-quality generics with brite™ digital therapy support.
